| Literature DB >> 35334803 |
Francisca Castro Mendes1,2,3, Inês Paciência2,3, João Cavaleiro Rufo2,3, Diana Silva1,2,3,4, Luís Delgado1,4, André Moreira1,2,3,4,5, Pedro Moreira2,3,5.
Abstract
Individual nutrients and bioactive compounds have been implicated in the expression of microRNAs (miRNAs), which are related to inflammation and asthma. However, evidence about the impact of diet is scarce. Therefore, we aimed to assess the association between dietary acid load and asthma-related miRNA in the exhaled breath condensate (EBC) of school-aged children. This cross-sectional analysis included 150 participants aged 7 to 12 years (52% girls) from a nested case-control study, which randomly selected 186 children attending 71 classrooms from 20 public schools located in city of Porto, Portugal. Dietary data were collected by one 24 h-recall questionnaire. Dietary acid load was assessed using the potential renal acid load (PRAL) and net endogenous acid production (NEAP) scores. Based on previous studies, eleven asthma-related miRNAs were chosen and analyzed in EBC by reverse transcription-quantitative real-time PCR. PRAL, NEAP and miRNAs were categorized as high or low according to the median. Logistic regression models were performed to assess the association between dietary acid load scores and miRNAs. Children in high dietary acid load groups (PRAL ≥ 14.43 and NEAP ≥ 55.79 mEq/day) have significantly increased odds of having high miR-133a-3p levels. In conclusion, higher dietary acid loads possibly modulate asthma-related miRNAs of school-aged children.Entities:
Keywords: NEAP; PRAL; asthma; children; diet; exhaled breath condensate; miRNAs
Mesh:
Substances:
Year: 2022 PMID: 35334803 PMCID: PMC8949211 DOI: 10.3390/nu14061147
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Participants’ characteristics.
| Females ( | Males ( | Total ( | |
|---|---|---|---|
| Age (years) | 9.0 (8.0; 9.0) | 9.0 (8.0; 10.0) | 9.0 (8.0; 9.0) * |
| Parental education level (years) 1, | |||
| ≤9 | 21 (36.84) | 27 (40.30) | 48 (32.0) |
| ≥10 and ≤12 | 17 (29.82) | 23 (34.33) | 40 (26.7) |
| >12 | 19 (33.33) | 17 (25.37) | 36 (24.0) |
| Nutritional supplementation 2, | 12 (16.90) | 8 (10.13) | 20 (13.3) |
| BMI categories 3, | |||
| Underweight | 4 (5.63) | 5 (6.33) | 9 (6.0) |
| Normal weight | 31 (43.66) | 32 (40.51) | 63 (42.0) |
| Overweight | 23 (32.39) | 17 (21.52) | 40 (26.7) |
| Obese | 13 (18.31) | 25 (31.65) | 38 (25.3) |
| Asthma 4, | 27 (38.03) | 25 (31.65) | 52 (34.7) |
| Energy (kcal/day) | 2011.30 | 229.21 | 2186.07 |
| Nutrient intake | |||
| Protein (g/day) | 98.76 (87.42; 106.68) | 93.64 (84.91; 105.42) | 95.43 (85.26; 108.83) |
| Phosphorus (mg/day) | 1469.09 | 1415.49 | 1443.84 |
| Potassium (mg/day) | 3187.89 | 2969.85 | 3155.24 |
| Magnesium (mg/day) | 282.33 (244.43; 310.37) | 263.32 (2.32.71; 316.83) | 269.41 (239.94; 310.36) |
| Calcium (mg/day) | 1002.81 | 993.10 | 998.38 |
| Dietary Acid Load (mEq/day) | |||
| PRAL | |||
| Low (<14.43) | 33 (46.48) | 42 (53.16) | 75 (50.0) |
| High (≥14.43) | 38 (53.52) | 37 (46.84) | 75 (50.0) |
| NEAP | |||
| Low (<55.79) | 35 (49.30) | 40 (50.63) | 75 (50.0) |
| High (≥55.79) | 36 (50.70) | 39 (50.63) | 75 (50.0) |
| MiRNAs | |||
| miR-21-5p | |||
| Low (<2.79) | 35 (49.30) | 40 (50.63) | 75 (50.0) |
| High (≥2.79) | 36 (50.70) | 39 (49.37) | 75 (50.0) |
| miR-126-3p | |||
| Low (<0.0568) | 36 (50.70) | 39 (49.37) | 75 (50.0) |
| High (≥0.0568) | 35 (49.30) | 40 (50.63) | 75 (50.0) |
| miR-133a-3p | |||
| Low (<0.0164) | 32 (45.07) | 43 (54.43) | 75 (50.0) |
| High (≥0.0164) | 39 (54.93) | 36 (45.57) | 75 (50.0) |
| miR-145-5p | |||
| Low (<0.58) | 31 (43.66) | 44 (55.70) | 75 (50.0) |
| High (≥0.58) | 40 (56.34) | 35 (44.30) | 75 (50.0) |
| miR-146a-5p | |||
| Low (<0.000665) | 47 (66.20) | 45 (56.90) | 92 (61.3) |
| High (≥0.000665) | 24 (33.80) | 34 (43.04) | 58 (38.7) |
| miR-155-5p | |||
| Low (<0.000119) | 53 (74.65) | 61 (51.90) | 114 (76.0) |
| High (≥0.000119) | 18 (25.35) | 18 (22.78) | 36 (24.0) |
| miR-221-3p | |||
| Low (<0.0831) | 34 (47.89) | 41 (51.90) | 75 (50.0) |
| High (≥0.0831) | 37 (52.11) | 38 (48.10) | 75 (50.0) |
| miR-328-3p | |||
| Low (<0.50) | 33 (46.48) | 42 (53.16) | 75 (50.0) |
| High (≥0.50) | 38 (53.52) | 37 (46.84) | 75 (50.0) |
| miR-423-3p | |||
| Low (<0.00107) | 51 (71.83) | 49 (62.03) | 100 (66.7) |
| High (≥0.00107) | 20 (28.17) | 30 (37.97) | 50 (33.3) |
Data are expressed as medians (25th-75th percentile), while categorical ones are described as counts and proportions. * p-value < 0.05; ** p-value < 0.01 1 Number of successfully completed years of formal schooling; 2 child took nutritional supplement in the previous 12 months; 3 According to US Centers for Disease Control; 4 Positive bronchodilation (defined by at least a 12% and over 200 mL increase in forced expiratory volume in 1 s (FEV1) after bronchodilation) or self-reported asthma diagnosed by a physician with reported asthma symptoms (wheezing, dyspnea, or dry cough) occurring in the previous 12 months. Abbreviations: PRAL: Potential renal acid load. NEAP: net endogenous acid production.
Association between PRAL and NEAP scores with EBC miRNAs in school-aged children.
| PRAL Score | NEAP Score | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | |||
| miR-21-5p | ||||||
| Unadjusted | 0.77 | 0.40; 1.45 | 0.766 | 0.69 | 0.36; 1.31 | 0.254 |
| Model 1 | 0.76 | 0.39; 1.49 | 0.418 | 0.71 | 0.36; 1.41 | 0.324 |
| Model 2 | 0.77 | 0.36; 1.61 | 0.480 | 0.87 | 0.41; 1.84 | 0.710 |
| miR-126-3p | ||||||
| Unadjusted | 1.62 | 0.85; 3.09 | 0.143 | 1.62 | 0.85; 3.09 | 0.143 |
| Model 1 | 1.60 | 0.81; 3.16 | 0.174 | 1.50 | 0.76; 1.00 | 0.242 |
| Model 2 | 1.36 | 0.65; 2.84 | 0.420 | 1.36 | 0.65; 2.86 | 0.417 |
| miR-133a-3p | ||||||
| Unadjusted |
|
| 0.006 |
|
| 0.002 |
| Model 1 |
|
| 0.004 |
|
| 0.002 |
| Model 2 |
|
| 0.008 |
|
| 0.006 |
| miR-145-5p | ||||||
| Unadjusted | 1.06 | 0.56; 2.00 | 0.870 | 1.06 | 0.56; 2.00 | 0.870 |
| Model 1 | 1.12 | 0.57; 2.21 | 0.744 | 1.06 | 0.54; 2.08 | 0.877 |
| Model 2 | 0.92 | 0.44; 1.95 | 0.828 | 1.05 | 0.49; 2.25 | 0.893 |
| miR-146a-5p | ||||||
| Unadjusted | 1.57 | 0.81; 3.05 | 0.181 | 1.12 | 0.58; 2.16 | 0.737 |
| Model 1 | 1.28 | 0.64; 2.58 | 0.495 | 0.96 | 0.47; 1.93 | 0.897 |
| Model 2 | 1.56 | 0.71; 3.41 | 0.270 | 1.06 | 0.48; 2.33 | 0.880 |
| miR-155-5p | ||||||
| Unadjusted | 0.55 | 0.26; 1.19 | 0.129 |
|
| 0.024 |
| Model 1 | 0.46 | 0.19; 1.08 | 0.073 |
|
| 0.008 |
| Model 2 | 0.61 | 0.24; 1.59 | 0.314 | 0.41 | 0.15; 1.10 | 0.076 |
| miR-221-3p | ||||||
| Unadjusted | 0.77 | 0.40; 1.45 | 0.415 | 0.77 | 0.40; 1.45 | 0.415 |
| Model 1 | 0.77 | 0.39; 1.51 | 0.450 | 0.73 | 0.37; 1.43 | 0.360 |
| Model 2 | 0.78 | 0.37; 1.63 | 0.505 | 0.77 | 0.37; 1.63 | 0.501 |
| miR-328-3p | ||||||
| Unadjusted | 1.06 | 0.56; 2.00 | 0.870 | 1.31 | 0.69; 2.48 | 0.415 |
| Model 1 | 1.08 | 0.55; 2.11 | 0.834 | 1.27 | 0.65; 2.51 | 0.487 |
| Model 2 | 1.08 | 0.51; 2.26 | 0.848 | 1.26 | 0.59; 2.67 | 0.553 |
| miR-423-3p | ||||||
| Unadjusted | 1.00 | 0.51; 1.97 | 0.999 | 0.70 | 0.35; 1.38 | 0.300 |
| Model 1 | 0.87 | 0.42; 1.79 | 0.708 | 0.63 | 0.30; 1.31 | 0.216 |
| Model 2 | 0.88 | 0.39; 1.99 | 0.762 | 0.61 | 0.27; 1.39 | 0.609 |
Abbreviations: PRAL: Potential renal acid load; NEAP: net endogenous acid production. Model 1, adjusted for total energy intake and nutritional supplementation; model 2, adjusted for the same variables as model 1 plus sex, age (year, continuous), BMI, asthma defined by medical diagnosis with asthma symptoms or +BD, school, and parental education.